Dr. Ana Ciurea, MD (she/her) is a Dermatologist in Houston, TX with over 17 years of experience. What is your opinion of Dr. Ana Ciurea, MD? Rate this provider below so other people can make informed decision.
Gender
Female (Approximately 68% of Dermatologists in Houston, TX are Female)
Education
Graduated in 1996
Degree Type
MD (Approximately 92% of Dermatologists in Houston, TX have MD degree)
Medical Specialties
Dermatologist (There are 200 Dermatologists available in Houston, TX, which is 32 times the average number of Dermatologists in similar U.S. locations)
Experience
17+ Years of Experience (About 12% more than the average Dermatologist in Houston, TX)
Languages Spoken
English
Common Conditions
Based on the training and education, Dr. Ana Ciurea, MD may treat patients with the following conditions. Please always check with Dr. Ana Ciurea, MD directly about which exact conditions he treats.
Imran T Baig, Quoc-Bao D Nguyen, Mary Alice Sallman Hickson, Ana Ciurea
JAAD case reports 2022-08-01
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.
Haider A Mejbel, Carlos A Torres-Cabala, Denái R Milton, Doina Ivan, Priyadharsini Nagarajan, Jonathan L Curry, Ana M Ciurea, Adam I Rubin, Wen-Jen Hwu, Victor G Prieto, Phyu P Aung
Archives of pathology & laboratory medicine 2021-08-01
Cutaneous Lesions of Multiple Myeloma of the Lower Extremity Masquerading as Squamous Cell Carcinoma.
Courtney A Clutter, Savina Aneja, Doina Ivan, Ana Ciurea, Sirunya Silapunt
Cureus 2020-11-03
Curative potential of hematopoietic stem cell transplantation for advanced psoriasis.
Stefan O Ciurea, Panupong Hansrivijit, Ana M Ciurea, Sharon Hymes, Julianne Chen, Gabriela Rondon, Chitra Hosing, Uday Popat, Richard E Champlin
American journal of hematology 2019-04-03
Surgical site identification with personal digital device: A prospective pilot study.
Leon Chen, Adam M Parsons, Alexander B Aria, Ana M Ciurea, Anisha B Patel, Christopher Chan, John R Griffin, Tri H Nguyen, Michael R Migden
Journal of the American Academy of Dermatology 2018-03-07
BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression.
Kumaran Mudaliar, Michael T Tetzlaff, Madeleine Duvic, Ana Ciurea, Sharon Hymes, Denái R Milton, Kenneth Y Tsai, Victor G Prieto, Carlos A Torres-Cabala, Jonathan L Curry
Human pathology 2015-12-18
Case of vemurafenib-induced Sweet's syndrome.
Jeffrey T Yorio, Steven R Mays, Ana M Ciurea, Philip R Cohen, Wei-Lien Wang, Wen-Jen Hwu, Nydia Gonzalez, Jessica L Richard, Kevin B Kim
The Journal of dermatology 2014-03-12
Eruptive squamous cell carcinomas after vemurafenib therapy.
Rana Mays, Jonathan Curry, Kevin Kim, Kenneth Tsai, Anita Arora, Farhan Khan, Marigdalia Ramirez-Fort, Ana Ciurea
Journal of cutaneous medicine and surgery
BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling.
Harina Vin, Sandra S Ojeda, Grace Ching, Marco L Leung, Vida Chitsazzadeh, David W Dwyer, Charles H Adelmann, Monica Restrepo, Kristen N Richards, Larissa R Stewart, Lili Du, Scarlett B Ferguson, Deepavali Chakravarti, Karin Ehrenreiter, Manuela Baccarini, Rosamaria Ruggieri, Jonathan L Curry, Kevin B Kim, Ana M Ciurea, Madeleine Duvic, Victor G Prieto, Stephen E Ullrich, Kevin N Dalby, Elsa R Flores, Kenneth Y Tsai
eLife 2013-11-05
Sorafenib suppresses JNK-dependent apoptosis through inhibition of ZAK.
Harina Vin, Grace Ching, Sandra S Ojeda, Charles H Adelmann, Vida Chitsazzadeh, David W Dwyer, Haiching Ma, Karin Ehrenreiter, Manuela Baccarini, Rosamaria Ruggieri, Jonathan L Curry, Ana M Ciurea, Madeleine Duvic, Naifa L Busaidy, Nizar M Tannir, Kenneth Y Tsai
Do you have any questions about plastic surgery, dermatology and cosmetic dentistry treatments? You can now post those questions in SelectWow Forum and have our experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of questions, all for FREE! Register today and join the conversation!
Get Directions
Call: (713) 792-6161
